YH12852, a Potent and Selective Receptor Agonist of 5‐hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional Constipation

Mechanisms, Evaluation, and Management of Chronic Constipation

(2020) Adil E. Bharucha et al.   GASTROENTEROLOGY

The novel, potent and highly selective 5-HT4 receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility

(2018) Eun Jeong Jeong et al.   BRITISH JOURNAL OF PHARMACOLOGY

Efficacy and safety of laxatives for chronic constipation in long-term care settings: A systematic review

(2018) N. Alsalimy et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders

(2018) Jutta Keller et al.   Nature Reviews Gastroenterology & Hepatology

YH12852, a potent and highly selective 5-HT4 receptor agonist, significantly improves both upper and lower gastrointestinal motility in a guinea pig model of postoperative ileus

(2017) Z. Hussain et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome

(2016) M. R. Blake et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride

(2015) J. Tack et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis

(2014) Anton Emmanuel et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

(2012) J. Tack et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Comprehensive assessment of gastric emptying with a stable isotope breath test

(2012) A. E. Bharucha et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study

(2010) M. Goldberg et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

905 A Novel Gastrointestinal Prokinetic, ATI-7505, Increased Spontaneous Bowel Movements (Sbms) in a Phase II, Randomized, Placebo-Controlled Study of Patients With Chronic Idiopathic Constipation (CIC)

(2010) Monica Palme et al.   GASTROENTEROLOGY

The Role of 5-HT3 and 5-HT4 Receptors in the Adaptive Mechanism of Colonic Transit Following the Parasympathetic Denervation in Rats

(2010) Weidong Tong et al.   JOURNAL OF SURGICAL RESEARCH

5-HT4 receptor agonists: similar but not the same

(2010) J. H. De Maeyer et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Role of serotonin in gastrointestinal motility and irritable bowel syndrome

(2009) Arbab Sikander et al.   CLINICA CHIMICA ACTA

Release of 5-Hydroxytryptamine From the Mucosa Is Not Required for the Generation or Propagation of Colonic Migrating Motor Complexes

(2009) Damien J. Keating et al.   GASTROENTEROLOGY

Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation

(2009) m. l. manini et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Localized Release of Serotonin (5-Hydroxytryptamine) by a Fecal Pellet Regulates Migrating Motor Complexes in Murine Colon

(2008) Dante J. Heredia et al.   GASTROENTEROLOGY

Serotonin and GI clinical disorders

(2008) Robin Spiller   NEUROPHARMACOLOGY